Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the benzamide class. It features a thiadiazepane ring system with multiple chiral centers and phenoxymethyl substituents. The molecule has been cataloged in chemical and drug databases (PubChem CID 445754; DrugBank DB03076; ChEMBL357057) as an experimental or research compound. There are no approved medical indications or clinical trials reported for this substance as of June 2025. Its mechanism of action and biological targets have not been characterized in the literature or major pharmacological databases[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-[[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide.